Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

Immunotherapy: Open Access : Citations & Metrics Report

Articles published in Immunotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Immunotherapy: Open Access has got h-index 6, which means every article in Immunotherapy: Open Access has got 6 average citations.

Following are the list of articles that have cited the articles published in Immunotherapy: Open Access.

  2021 2020 2019 2018 2017

Year wise published articles

33 11 4 5 15

Year wise citations received

26 13 13 17 22
Journal total citations count 135
Journal impact factor 0.92
Journal 5 years impact factor 1.41
Journal cite score 2.00
Journal h-index 6
Journal h-index since 2017 6
Important citations

An overview of cancer immunotherapeutic strategies

Emerging targets in cancer immunotherapy

Multiplexed digital spatial profiling of invasive breast tumors from black and white women

Development of a multiplex immunohistochemistry workflow to investigate the immune microenvironment in mouse models of inflammatory bowel disease and colon cancer

Assessing the reproducibility of labelled antibody binding in quantitative multiplexed immuno-mass spectrometry imaging

Multiparametric profiling of single nanoscale extracellular vesicles by combined atomic force and fluorescence microscopy: correlation and heterogeneity in their molecular and biophysical features

Fractal: signal amplification of immunofluorescence via cyclic staining of target molecules

A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment

Types of blotting

Selectively targeting haemagglutinin antigen to chicken cd83 receptor induces faster and stronger immunity against avian influenza

Targeting haemagglutinin antigen of avian influenza virus to chicken immune cell receptors dec205 and cd11c induces differential immune-potentiating responses

Activation of dendritic cells by targeted dna: a potential addition to the armamentarium for anti-cancer immunotherapy

Enhancing protective efficacy of poultry vaccines through targeted delivery of antigens to antigen-presenting cells

?-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through stat3 activation in gastric cancer

Termination of transcription of lat increases the amounts of icp0 mrna but does not alter the course of hsv-1 infection in latently infected murine ganglia

The combination therapy of oncolytic hsv-1 armed with anti-pd-1 antibody and il-12 enhances anti-tumor efficacy

Enhancing therapeutic efficacy of oncolytic herpes simplex virus with mek inhibitor trametinib in some braf or kras-mutated colorectal or lung carcinoma models

Usp18 and usp20 restrict ohsv-1 replication in resistant human oral squamous carcinoma cell line scc9 and affect the viability of scc9 cells

High accumulation of mx2 renders limited multiplication of oncolytic herpes simplex virus-1 in human tumor cells

Identification of rab27a as a host factor for oncolytic herpes virus susceptibility to tumor cells

Relevant Topics